← All companies

Cresilon, Inc.

Consumer

Company overview

Cresilon develops advanced hemostatic gel technology designed to stop bleeding rapidly without requiring manual pressure. TRAUMAGEL is its gel for controlling external moderate to severe bleeding. VETIGEL is a hemostatic gel for veterinary use, the first hemostatic gel in the veterinary market, with over 65,000 procedures performed globally.

Cresilon is headquartered in Brooklyn, New York. It was named to Fast Company's World's 50 Most Innovative Companies of 2026, ranking first in medical devices and forty-sixth overall. Cresilon, Inc is an H-1B sponsor.

Industry
Consumer
Headquarters
Brooklyn, United States

Filters

Create your account

Create an account to save jobs and track applications.